[Kaposi's sarcoma].
In recent years large amounts of findings have accumulated about Kaposi's sarcoma, a virus induced angioproliferative disorder appearing in four clinical forms: classical, epidemic, endemic and iatrogenic, as it has been in focus of not only from the dermatologic but also from the viral tumorgenesis perspective. The common characteristics are the histopathological appearance, the causative role of the human herpesvirus 8 and the similar clinical picture (bluish-red macules, papules, and nodes). Frequency of the distinguished clinical forms differs with geographical location. Viruses, genetic -, and environmental factors have been shown to play a role in the pathomechanism of the disease, of which the most important is the human herpesvirus-8. The mechanisms by which viral proteins and virus infection enhance tumorgenesis and alter immune functions directed at cells have been studied in detail. During the initiation of tumorgenesis, virus induced viral and host cell products (cytokines, receptors and oncogens) initiate inflammatory and angiogenic polyclonal cell proliferation, which later, by the synergistic action of other viruses and/or environmental factors, give rise to malignant proliferation and allow the selected cell to clonally expand and behave like a true malignant tumor. In light of newly published results the authors not only present the clinical appearances and summarize diagnostic possibilities and the pathomechanism of the disease, but also give a thorough overview of the therapeutic tools of Kaposi's sarcoma, and share their experiences obtained during the follow-up of classical Kaposi's sarcoma patients.
Remenyik
Eva
E
Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Bor- és Nemikórtani Klinika, Debrecen. remenyik@dote.hu
Juhász
Attila
A
Hunyadi
János
J
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000628:therapy; D000998:Antiviral Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D019288:Herpesvirus 8, Human / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D015994:Incidence; D015513:Oncogene Proteins / Q000378:metabolism; D012514:Sarcoma, Kaposi / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D012698:Serologic Tests; D017678:Sex Distribution; D015229:Sexually Transmitted Diseases, Viral / Q000175:diagnosis / Q000628:therapy
D000998:Antiviral Agents; D015513:Oncogene Proteins